Economic comparison of methods of wound closure: wound closure strips vs. sutures and wound adhesives.

International Wound Journal
William T ZempskyEdwin C Hedbloom

Abstract

Our objective was to review and assess the treatment of low-tension wounds and evaluate the cost-effectiveness of wound closure methods. We used a health economic model to estimate cost/closure of adhesive wound closure strips, tissue adhesives and sutures. The model incorporated cost-driving variables: application time, costs and the likelihood and costs of dehiscence and infection. The model was populated with variable estimates derived from the literature. Cost estimates and cosmetic results were compared. Parameter values were estimated using national healthcare and labour statistics. Sensitivity analyses were used to verify the results. Our analysis suggests that adhesive wound closure strips had the lowest average cost per laceration ($7.54), the lowest cost per infected laceration ($53.40) and the lowest cost per laceration with dehiscence ($25.40). The costs for sutures were $24.11, $69.91 and $41.91, respectively; the costs for tissue adhesives were $28.77, $74.68 and $46.68, respectively. The cosmetic outcome for all three treatments was equivalent. We conclude adhesive wound closure strips were both a cost-saving and a cost-effective alternative to sutures and tissue adhesives in the closure of low-tension lacerations.

References

Apr 1, 1973·Archives of Dermatology·W A AkersT A Cortese
Jun 1, 1995·Journal of Pediatric Surgery·F N ElmasalmeM S Zuberi
Jan 1, 1995·The American Journal of Emergency Medicine·M OrlinskyH L Slajer
Feb 1, 1993·The Australian and New Zealand Journal of Surgery·S M Liew, C S Haw
Jul 1, 1993·Annals of Emergency Medicine·J S ApplebaumD Applebaum
May 21, 1997·JAMA : the Journal of the American Medical Association·J QuinnP Johns
May 21, 1997·JAMA : the Journal of the American Medical Association·A T Trott
Mar 10, 1998·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·A J SingerJ V Quinn
Jun 17, 1998·The Journal of Pediatrics·T B BrunsJ V Quinn
Nov 12, 1998·Plastic and Reconstructive Surgery·D M ToriumiA Bagal
Apr 7, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·M H OsmondT P Klassen
Jun 1, 2000·The American Journal of Emergency Medicine·A D PerronR Schafermeyer
May 15, 2001·BJU International·V J FerliseJ G Barone
Feb 16, 2002·Holistic Nursing Practice·Louise Autio, Karen Koozer Olson
Aug 2, 2002·Postgraduate Medical Journal·D MaharajV Naraynsingh
Feb 8, 2003·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Ken J FarionNatasha Wiebe
Oct 26, 1963·British Medical Journal·N G ROTHNIE, G W TAYLOR
Feb 11, 2004·American Journal of Surgery·Adam J Singer, Henry C Thode

❮ Previous
Next ❯

Citations

May 11, 2011·Journal of Cardiac Surgery·Harold L LazarHoward J Cabral
Apr 23, 2014·International Wound Journal·Valerio FinocchiDamiano Tambasco
Sep 20, 2011·Surgical Innovation·Ioannis D GkegkesMatthew E Falagas
Jun 28, 2012·Foot & Ankle International·Peter StavrouGeorge Dracopoulos
Sep 28, 2007·Emergency Radiology·Alicia C Arnold, Aaron Sodickson
May 31, 2019·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Kristina LeeNavin Mani
Jun 19, 2018·Aesthetic Surgery Journal·Russell W H Kridel, Sean W Delaney
Jul 26, 2002·The Cochrane Database of Systematic Reviews·K FarionN Wiebe
Jul 15, 2021·Case Reports in Emergency Medicine·John Ko, Jeffrey S Freed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.